Differentiating Secondary adrenal insufficiency from other diseases: Difference between revisions
Usama Talib (talk | contribs) |
|||
Line 41: | Line 41: | ||
! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ! align="center" style="background:#4479BA; color: #FFFFFF;" |Other | ||
|- | |- | ||
! colspan="14" |<big>Differentiating amongst adrenal insufficiencies</big> | ! colspan="14" align="center" style="background:#4479BA; color: #FFFFFF;" |<big>Differentiating amongst adrenal insufficiencies</big> | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" |Chronic | |style="padding: 5px 5px; background: #DCDCDC;" align="center" |Chronic | ||
Line 122: | Line 122: | ||
* [[Fludrocortisone]] - 0.1 to 0.2 mg PO q daily after initial stabilization | * [[Fludrocortisone]] - 0.1 to 0.2 mg PO q daily after initial stabilization | ||
|- | |- | ||
! colspan="15" |'''<big>Differentiating Adrenal Insufficiency from other diseases</big>''' | ! colspan="15" align="center" style="background:#4479BA; color: #FFFFFF;" |'''<big>Differentiating Adrenal Insufficiency from other diseases</big>''' | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" align="center" | | |style="padding: 5px 5px; background: #DCDCDC;" align="center" | |
Revision as of 18:26, 3 October 2017
Adrenal insufficiency Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Differentiating Secondary adrenal insufficiency from other diseases On the Web |
American Roentgen Ray Society Images of Differentiating Secondary adrenal insufficiency from other diseases |
FDA on Differentiating Secondary adrenal insufficiency from other diseases |
CDC on Differentiating Secondary adrenal insufficiency from other diseases |
Differentiating Secondary adrenal insufficiency from other diseases in the news |
Blogs on Differentiating Secondary adrenal insufficiency from other diseases |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].
OR
[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].
Adrenal Insufficiency
Acute/
Chronic |
Disease | Clinical history/findings | Causes | Laboratory findings | Medical therapy | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hypotension | Skin
pigmentation/ findings |
Fatigue | Anorexia/
weightloss |
Abdominal pain | Muscle
weakness |
Other history
findings |
Hypo
natremia |
Cortisol levels | Gold Standard | Other | ||||
Differentiating amongst adrenal insufficiencies | ||||||||||||||
Chronic | Primary adrenal | + | + | + | + | + | + |
|
+ | Low | Cosyntropin/ ACTH stimulation test |
| ||
Chronic | Secondary adrenal
insufficiency |
± | – | + | + | – | ± |
|
|
– | Normal | Cosyntropin/ ACTH stimulation test |
|
|
Acute | Acute adrenal insufficiency/ Acute adrenal crisis | ++ | ± | + | + | + | ± |
|
+ | Normal to Low | Cosyntropin/ ACTH stimulation test |
|
| |
Differentiating Adrenal Insufficiency from other diseases | ||||||||||||||
Adrenal hemorrhage/ Waterhouse Friderichsen syndrome | orthostatic | ± | + | ± | + | – |
|
+ | Normal to low | Cosyntropin/ ACTH stimulation test |
|
| ||
Congenital adrenal hyperplasia (CAH) | Normal to hypertension | ±
(can be indicator of Uncontrolled CAH)[6] |
– | – | – | – |
|
|
± | Low | Cosyntropin/ ACTH stimulation test |
|
| |
Syndrome of inappropriate antidiuretic hormone (SIADH) | – | – | – | – | – | – |
|
+ | Normal | Water deprivation test |
|
| ||
Salt-depletion nephritis/ Salt losing nephropathy | + | – | – | – | + Flank pain | – | ++[9] | High | Genetic study | <15:1 BUN:CR |
| |||
Anorexia nervosa | + | – | + | + | – | + |
|
– | High | Psychiatric condition | – |
|
References
- ↑ Patnaik MM, Deshpande AK (2008). "Diagnosis--Addison's disease secondary to tuberculosis of the adrenal glands". Clin Med Res. 6 (1): 29. doi:10.3121/cmr.2007.754a. PMC 2442022. PMID 18591375.
- ↑ Bhattacharjee R, Sharma A, Rays A, Thakur I, Sarkar D, Mandal B, Mookerjee SK, Chatterjee SK, Chowdhury PR (2013). "Addison's disease presenting with muscle spasm". J Assoc Physicians India. 61 (9): 675–6. PMID 24772716.
- ↑ Ray A, Sanyal D (2016). "A rare case of Addison's disease due to bilateral adrenal histoplasmosis presenting with hypoglycaemia". J Assoc Physicians India. 64 (1): 45–46. PMID 27727656.
- ↑ Choudhary N, Aggarwal I, Dutta D, Ghosh AG, Chatterjee G, Chowdhury S (2013). "Acquired perforating dermatosis and Addison's disease due to disseminated histoplasmosis: Presentation and clinical outcomes". Dermatoendocrinol. 5 (2): 305–8. doi:10.4161/derm.22677. PMC 3772918. PMID 24194970.
- ↑ Schimke KE, Greminger P, Brändle M (2009). "Secondary adrenal insufficiency due to opiate therapy - another differential diagnosis worth consideration". Exp. Clin. Endocrinol. Diabetes. 117 (10): 649–51. doi:10.1055/s-0029-1202851. PMID 19373753.
- ↑ Patel FB, Newman SA, Norton SA (2016). "Addisonian-Like Hyperpigmentation as an Indicator of Uncontrolled Congenital Adrenal Hyperplasia". Skinmed. 14 (1): 53–4. PMID 27072733.
- ↑ Seyberth HW (2016). "Pathophysiology and clinical presentations of salt-losing tubulopathies". Pediatr. Nephrol. 31 (3): 407–18. doi:10.1007/s00467-015-3143-1. PMID 26178649.
- ↑ Sayin B (2015). "Tacrolimus-Induced Salt Losing Nephropathy Resolved After Conversion to Everolimus". Transplant Direct. 1 (9): e37. doi:10.1097/TXD.0000000000000538. PMC 4946484. PMID 27500237.
- ↑ Yoshioka K, Nishio M, Sano S, Sakurai K, Yamagami K, Yamashita Y (2009). "Development of Severe Hyponatremia due to Salt-Losing Nephropathy after Esophagectomy for Esophageal Cancer". Case Rep Med. 2009: 241283. doi:10.1155/2009/241283. PMC 2771150. PMID 19888422.